We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
16 Feb 2023 - 18 Feb 2023

Skin Autofluorescence Detects Heart Disease and Diabetes

By HospiMedica International staff writers
Posted on 17 Dec 2018
Print article
Image: The AGE reader used in the study (Photo courtesy of Diagnoptics Technologies).
Image: The AGE reader used in the study (Photo courtesy of Diagnoptics Technologies).
Non-invasive skin autofluorescence can predict type 2 diabetes (T2D), cardiovascular disease (CVD), and mortality in the general population, according to a new study.

Researchers at University Medical Center Groningen (UMCG; The Netherlands), Medical Center Leeuwarden (The Netherlands), and other institutions conducted a prospective analysis study to examine if the measurement of skin autofluorescence can predict risk of incident T2D, CVD, and mortality. The study included 72,880 participants of the Dutch Lifelines Cohort Study, who underwent baseline investigations between 2007-2013, had validated baseline skin autofluorescence values available, and were not known to have T2D or CVD.

The results revealed that after a median follow-up of four years, 1.4% of participants developed T2D, 1.7% were diagnosed with CVD, and 1.3% had died. Baseline skin autofluorescence was elevated in all three groups, compared with those who lived and remained free of the two diseases. The researchers also found that skin autofluorescence predicted development of T2D, CVD and mortality independently of traditional risk factors, such as the metabolic syndrome, blood glucose, and HbA1c. The study was published on November 21, 2018, in Diabetologia.

“Both previous and present findings support the clinical utility of skin autofluorescence as a first screening method for type two diabetes, cardiovascular disease, and mortality,” concluded lead author Robert van Waateringe, MD, of UMCG, and colleagues. “The quick, noninvasive, measurement of skin autofluorescence may even allow use in nonmedical settings or public locations such as supermarkets, pharmacies, or drug stores as a first estimate of risk.”

Skin autofluorescence is a noninvasive method of assessing the accumulation of advanced glycation end products (AGEs) with fluorescent properties in dermal tissue. AGEs are formed in a multistep process by glycation and oxidation of free amino groups of proteins, lipids, and nucleic acids. They can cause an increase in vascular stiffness and elevated blood pressure, accelerate the progression of atherosclerosis, and may also worsen hyperglycemia by increasing inflammation and oxidative stress in beta cells. Skin autofluorescence increases with ageing, is elevated in people with T2D, as well as with the individual components of metabolic syndrome.

Related Links:
University Medical Center Groningen
Medical Center Leeuwarden

Gold Supplier
Creatinine Meter
StatSensor Xpress Creatinine Meter
Mobile Radiography System
NeuVision 550M (Plus)
Radiography System
Riviera SPV
Vital Signs Monitor
Aurus 20 A

Print article



view channel
Image: MyoVista Wavelet technology utilizes AI for early detection of heart disease (Photo courtesy of Heart Test Laboratories)

Novel ECG Technology Utilizes AI for Early Detection of Heart Disease

Cardiovascular disease is responsible for 17.9 million deaths every year, or about 32% of all deaths worldwide. Every week, millions of electrocardiographs (ECGs) are performed across the world, making... Read more

Surgical Techniques

view channel
Image: The LithoVue Elite System (Photo courtesy of Boston Scientific)

First Ever Ureteroscope System Monitors Intrarenal Pressure in Real-Time During Ureteroscopy Procedures

About one in 10 people can develop a kidney stone at some point in their lives. Ureteroscopy is commonly performed by urologists to diagnose and treat various problems in the urinary tract, particularly... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Point of Care

view channel
Image: Steripath improves the diagnostic accuracy and timeliness of sepsis test results (Photo courtesy of Magnolia)

All-in-One Device Reduces False-Positive Diagnostic Test Results for Bloodstream Infections

Blood cultures are considered the gold standard diagnostic test for the detection of blood stream infections, such as sepsis. However, positive blood culture results can be frequently wrong, and about... Read more


view channel
Image: The global patient positioning systems market is projected to reach USD 1.7 billion by 2027 (Photo courtesy of Pexels)

Global Patient Positioning Systems Market Driven by Increasing Chronic Diseases

The global patient positioning systems market is projected to grow at a CAGR of 4% from USD 1.4 billion in 2022 to USD 1.7 billion by 2027, driven by increasing technological advancements in medical devices,... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.